Which drugs are most likely to be approved in Tenosynovial Giant Cell Tumor?

Tenosynovial Giant Cell Tumor disease is an indication for drug development with over 10 pipeline drugs currently active according to GlobalData.

AbbVie purchases neuroscience developer Cerevel for $8.7 billion

Abbvie announced Wednesday that it will purchase Cerevel Therapeutics and its pipeline of experimental neurological and psychiatric medications for $8.7 billion. The deal marks the

December 6, 2023

GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates – Psychedelic Alpha

DUBLIN, Ireland, Aug. 23, 2023 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and

August 23, 2023

How efforts to cancel medical debt could wind up benefitting hospitals

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.